177 related articles for article (PubMed ID: 18321487)
1. Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women.
Achrekar SK; Modi DN; Desai SK; Mangoli VS; Mangoli RV; Mahale SD
Fertil Steril; 2009 Feb; 91(2):432-9. PubMed ID: 18321487
[TBL] [Abstract][Full Text] [Related]
2. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.
Huang X; Li L; Hong L; Zhou W; Shi H; Zhang H; Zhang Z; Sun X; Du J
Clin Endocrinol (Oxf); 2015 Apr; 82(4):577-83. PubMed ID: 25132286
[TBL] [Abstract][Full Text] [Related]
3. Absence of follicle-stimulating hormone receptor activating mutations in women with iatrogenic ovarian hyperstimulation syndrome.
d'Alva CB; Serafini P; Motta E; Kohek MB; Latronico AC; Mendonca BB
Fertil Steril; 2005 Jun; 83(6):1695-9. PubMed ID: 15950638
[TBL] [Abstract][Full Text] [Related]
4. Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH.
Tarlatzis BC; Griesinger G; Leader A; Rombauts L; Ijzerman-Boon PC; Mannaerts BM
Reprod Biomed Online; 2012 Apr; 24(4):410-9. PubMed ID: 22386594
[TBL] [Abstract][Full Text] [Related]
5. Kinase insert domain receptor/vascular endothelial growth factor receptor 2 (KDR) genetic variation is associated with ovarian hyperstimulation syndrome.
O'Brien TJ; Harralson AF; Tran T; Gindoff I; Orkunoglu-Suer FE; Frankfurter D; Gindoff P
Reprod Biol Endocrinol; 2014 May; 12():36. PubMed ID: 24886133
[TBL] [Abstract][Full Text] [Related]
6. Association of follicle-stimulating hormone receptor polymorphisms with ovarian response in Chinese women: a prospective clinical study.
Yan Y; Gong Z; Zhang L; Li Y; Li X; Zhu L; Sun L
PLoS One; 2013; 8(10):e78138. PubMed ID: 24167601
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.
Griesinger G; Verweij PJ; Gates D; Devroey P; Gordon K; Stegmann BJ; Tarlatzis BC
PLoS One; 2016; 11(3):e0149615. PubMed ID: 26950065
[TBL] [Abstract][Full Text] [Related]
8. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY
Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114
[TBL] [Abstract][Full Text] [Related]
9. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism.
Daelemans C; Smits G; de Maertelaer V; Costagliola S; Englert Y; Vassart G; Delbaere A
J Clin Endocrinol Metab; 2004 Dec; 89(12):6310-5. PubMed ID: 15579795
[TBL] [Abstract][Full Text] [Related]
10. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation.
Behre HM; Greb RR; Mempel A; Sonntag B; Kiesel L; Kaltwasser P; Seliger E; Röpke F; Gromoll J; Nieschlag E; Simoni M
Pharmacogenet Genomics; 2005 Jul; 15(7):451-6. PubMed ID: 15970792
[TBL] [Abstract][Full Text] [Related]
11. The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation.
Nenonen HA; Lindgren IA; Prahl AS; Trzybulska D; Kharraziha I; Hultén M; Giwercman YL; Henic E
Pharmacogenet Genomics; 2019 Jul; 29(5):114-120. PubMed ID: 30829738
[TBL] [Abstract][Full Text] [Related]
12. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.
Manzanares MA; Gómez-Palomares JL; Ricciarelli E; Hernández ER
Fertil Steril; 2010 Mar; 93(4):1215-9. PubMed ID: 19200978
[TBL] [Abstract][Full Text] [Related]
13. Patient preference for a long-acting recombinant FSH product in ovarian hyperstimulation in IVF: a discrete choice experiment.
van den Wijngaard L; Rodijk IC; van der Veen F; Gooskens-van Erven MH; Koks CA; Verhoeve HR; Mol BW; van Wely M; Mochtar MH
Hum Reprod; 2015 Feb; 30(2):331-7. PubMed ID: 25432926
[TBL] [Abstract][Full Text] [Related]
14. Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes.
Schirmer DA; Kulkarni AD; Zhang Y; Kawwass JF; Boulet SL; Kissin DM
Fertil Steril; 2020 Sep; 114(3):567-578. PubMed ID: 32680613
[TBL] [Abstract][Full Text] [Related]
15. Impaired outcome of controlled ovarian hyperstimulation in women with thyroid autoimmune disease.
Magri F; Capelli V; Gaiti M; Brambilla E; Montesion L; Rotondi M; Spinillo A; Nappi RE; Chiovato L
Thyroid; 2013 Oct; 23(10):1312-8. PubMed ID: 23556516
[TBL] [Abstract][Full Text] [Related]
16. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.
Huber M; Hadziosmanovic N; Berglund L; Holte J
Fertil Steril; 2013 Nov; 100(5):1270-6. PubMed ID: 23931964
[TBL] [Abstract][Full Text] [Related]
17. Can FSH co-trigger prevent OHSS?
Rosen MP; Meldrum DR
Fertil Steril; 2012 Mar; 97(3):534-5. PubMed ID: 22285746
[TBL] [Abstract][Full Text] [Related]
18. Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response.
Lledo B; Guerrero J; Turienzo A; Ortiz JA; Morales R; Ten J; Llacer J; Bernabeu R
Pharmacogenet Genomics; 2013 May; 23(5):262-8. PubMed ID: 23470615
[TBL] [Abstract][Full Text] [Related]
19. Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.
Bar-Hava I; Mizrachi Y; Karfunkel-Doron D; Omer Y; Sheena L; Carmon N; Ben-David G
Fertil Steril; 2016 Aug; 106(2):330-3. PubMed ID: 27114332
[TBL] [Abstract][Full Text] [Related]
20. Effect of follicle-stimulating hormone receptor Asn680Ser polymorphism on the outcomes of controlled ovarian hyperstimulation: an updated meta-analysis of 16 cohort studies.
Tang H; Yan Y; Wang T; Zhang T; Shi W; Fan R; Yao Y; Zhai S
J Assist Reprod Genet; 2015 Dec; 32(12):1801-10. PubMed ID: 26481502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
